Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sliepen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|November 15, 2019
The nociceptin/orphanin FQ receptor system as a target to alleviate cancer-induced bone pain in rats: Model validation and pharmacological evaluationSonny H J Sliepen, Johanna Korioth, Thomas Christoph, et al.
Cancer Immunology, Immunotherapy : CII|March 6, 2010
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapyGerty Schreibelt, Jurjen Tel, Kwinten H E W J Sliepen, et al.
Injury|October 28, 2022
Outcome and risk factors for recurrence of early onset fracture-related infections treated with debridement, antibiotics and implant retention: Results of a large retrospective multicentre cohort studyM A S Buijs, J van den Kieboom, J Sliepen, et al.
Injury|June 27, 2026
The impact of duration of infection on outcome of debridement, antimicrobial treatment and implant retention in fracture-related infections of the lower leg: A multicentre retrospective cohort studyJ Sliepen, M A S Buijs, M Wouthuyzen-Bakker, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|November 15, 2019
The nociceptin/orphanin FQ receptor system as a target to alleviate cancer-induced bone pain in rats: Model validation and pharmacological evaluationSonny H J Sliepen, Johanna Korioth, Thomas Christoph, et al.
Cancer Immunology, Immunotherapy : CII|March 6, 2010
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapyGerty Schreibelt, Jurjen Tel, Kwinten H E W J Sliepen, et al.
Injury|October 28, 2022
Outcome and risk factors for recurrence of early onset fracture-related infections treated with debridement, antibiotics and implant retention: Results of a large retrospective multicentre cohort studyM A S Buijs, J van den Kieboom, J Sliepen, et al.
Injury|June 27, 2026
The impact of duration of infection on outcome of debridement, antimicrobial treatment and implant retention in fracture-related infections of the lower leg: A multicentre retrospective cohort studyJ Sliepen, M A S Buijs, M Wouthuyzen-Bakker, et al.
Pageof 1